Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Version 64 was added on 2026-07-31, introducing a Quality Control status Has Not Concluded and new entries for Adverse Events and Study Status. The record now shows a Returned date of 2026-08-24 and a revision update to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.3%
    Check dated 2026-08-29T23:41:15.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5 on the page, indicating a newer build of the interface. This is a minor update to the site's metadata rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-08-08T23:15:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page shows an updated revision tag from v3.6.3 to v3.6.4, indicating a small platform update to the Record History view. The change does not appear to alter study information or navigation.
    Difference
    0.0%
    Check dated 2026-07-25T17:04:45.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Returned: 2026-07-10 is now shown and the QC status is Has Not Concluded. New sections have been added to the history view, including More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Documents Section, Contacts/Locations, and an updated Study Status entry (2026-06-15, 63).
    Difference
    0.6%
    Check dated 2026-07-18T13:33:31.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page footer’s revision label was updated from v3.6.2 to v3.6.3, indicating a small site update. This metadata change does not alter study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-07-04T04:20:13.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This reflects a small version update shown on the page.
    Difference
    0.0%
    Check dated 2026-06-27T02:26:52.000Z thumbnail image

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.